Stock SVA SERNOVA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News Sernova Corp. Toronto S.E.

Equities

SVA

CA81732W1041

Delayed Toronto S.E.
Other stock markets
 03:48:16 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.425 CAD -1.16% Intraday chart for Sernova Corp. -7.53% -38.57%
Apr. 02 Sernova Corp. Provides Positive Clinical and Platform Portfolio Update CI
Mar. 19 Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors
AQ
Sernova Provides Positive Clinical and Platform Portfolio Update
AQ
Sernova Corp. Provides Positive Clinical and Platform Portfolio Update
CI
Sernova : INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
PU
Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024
CI
Sernova : Corporate Presentation March 2024
PU
Sernova Corp. Announces CFO Changes
CI
Sernova Announces Management Developments
AQ
Sernova Corp. Reports Earnings Results for the Full Year Ended October 31, 2023
CI
Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones
AQ
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
MT
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
AQ
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System at the 2023 IPITA-IXA-CTRMS Joint Congress
AQ
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
AQ
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress
AQ
Sernova Corp. Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System? at the 2023 IPITA-IXA-CTRMS Joint Congress
CI
Sernova Announces Positive Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial
MT
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
AQ
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System? for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
CI
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SVA Stock
  4. SVA Stock
  5. News Sernova Corp.